Clinical Trial Update: Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed evaluating immunogenicity and safety of GlaxoSmithKline's novel HPV vaccine in young adult women; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Papillomavirus Vaccines-induced Conditions

Drugs mentioned

• GSK novel HPV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus, Papillomavirus Vaccines | Phase 2 | Status: COMPLETED | Results posted: 2015-02-10